{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:32:51Z","timestamp":1767839571415,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T00:00:00Z","timestamp":1225411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1208\/s12249-008-9143-8","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T18:28:52Z","timestamp":1225391332000},"page":"1102-1109","source":"Crossref","is-referenced-by-count":89,"title":["Preparation and Solid-State Characterization of Inclusion Complexes Formed Between Miconazole and Methyl-\u03b2-Cyclodextrin"],"prefix":"10.1208","volume":"9","author":[{"given":"Andreza","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Ana","family":"Figueiras","sequence":"additional","affiliation":[]},{"given":"Delfim","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Veiga","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,10,31]]},"reference":[{"key":"9143_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1021\/js950534b","volume":"85","author":"T. Loftsson","year":"1996","unstructured":"T. Loftsson, and M. E. Brewster. Pharmaceutical applications of cyclodextrins.1. Drug solubilization and stabilization. J. Pharm. Sci.\n                  85:1017\u20131025 (1996).","journal-title":"J. Pharm. Sci."},{"key":"9143_CR2","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1021\/cr970022c","volume":"98","author":"J. Szejtli","year":"1998","unstructured":"J. Szejtli. Introduction and general overview cyclodextrin chemistry. Chem. Rev.\n                  98:1743\u20131753 (1998).","journal-title":"Chem. Rev."},{"key":"9143_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1023\/A:1012136608249","volume":"14","author":"V. J. Stella","year":"1997","unstructured":"V. J. Stella, and R. A. Rajewski. Cyclodextrins: Their future in drug formulation and delivery. Pharm. Res.\n                  14:556\u2013567 (1997).","journal-title":"Pharm. Res."},{"key":"9143_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","volume":"59","author":"T. Loftsson","year":"2007","unstructured":"T. Loftsson, and E. Brewster. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliver. Rev.\n                  59:645\u2013666 (2007).","journal-title":"Adv. Drug Deliver. Rev."},{"key":"9143_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0168-3659(87)90084-8","volume":"6","author":"J. Pitha","year":"1987","unstructured":"J. Pitha. Amorphous water soluble derivatives of cyclodextrins: From test tube to patient. J. Control Release. 6:309\u2013313 (1987).","journal-title":"J. Control Release"},{"key":"9143_CR6","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1021\/cr970014w","volume":"98","author":"A. R. Hedges","year":"1998","unstructured":"A. R. Hedges. Industrial applications of cyclodextrins. Chem. Rev.\n                  98:2035\u20132044 (1998).","journal-title":"Chem. Rev."},{"key":"9143_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0169-409X(98)00054-4","volume":"36","author":"F. W. Merkus","year":"1999","unstructured":"F. W. Merkus, J. C. Verhoef, E. Marttin, S. G. Romeijn, W. A. V. D. Kuy, and H. G. Schipper. Cyclodextrins in nasal drug delivery. Adv. Drug Deliv. Rev.\n                  36:41\u201357 (1999).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9143_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0168-3659(98)00182-5","volume":"59","author":"M. Masson","year":"1999","unstructured":"M. Masson, T. Loftsson, G. Masson, and E. Stefansson. Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. J. Control Release. 59:107\u2013118 (1999).","journal-title":"J. Control Release"},{"key":"9143_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jps.20350","volume":"94","author":"L. Boulmedarat","year":"2005","unstructured":"L. Boulmedarat, A. Bochot, S. Lesieur, and E. Fattal. Evaluation of buccal methyl-beta-cyclodextrin toxicity on human oral epithelial cell culture model. J. Pharm. Sci.\n                  94:1300\u20131309 (2005).","journal-title":"J. Pharm. Sci."},{"key":"9143_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nrd1576","volume":"3","author":"M. E. Davis","year":"2004","unstructured":"M. E. Davis, and M. E. Brewster. Cyclodextrin-based pharmaceutics: Past, present and future. Nat. Rev. Drug Dis.\n                  3:1023\u20131035 (2004).","journal-title":"Nat. Rev. Drug Dis."},{"key":"9143_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-5173(01)00761-X","volume":"225","author":"T. Loftsson","year":"2001","unstructured":"T. Loftsson, and M. Masson. Cyclodextrins in topical drug formulations: Theory and practice. Int. J. Pharm.\n                  225:15\u201330 (2001).","journal-title":"Int. J. Pharm."},{"key":"9143_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-5173(98)00103-3","volume":"169","author":"G. Piel","year":"1998","unstructured":"G. Piel, B. Evrard, M. Fillet, G. Llabres, and L. Delattre. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int. J. Pharm.\n                  169:15\u201322 (1998).","journal-title":"Int. J. Pharm."},{"key":"9143_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0031-6865(93)90007-S","volume":"68","author":"M. Pedersen","year":"1993","unstructured":"M. Pedersen, S. Pedersen, A. M. Sorensen, A. Scarpelline, S. Skytte, and C. Slot. Polymorphism of miconazole during preparation of solid systems of the drug and b-cyclodextrins. Pharma. Acta Helv.\n                  68:43\u201347 (1993).","journal-title":"Pharma. Acta Helv."},{"key":"9143_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/js970361l","volume":"87","author":"S. Tenjarla","year":"1998","unstructured":"S. Tenjarla, P. Puranajoti, R. Kasina, and T. Mandal. Preparation, characterization, and evaluation of miconazole\u2013cyclodextrin complexes for improved oral and topical delivery. J. Pharm. Sci.\n                  87:425\u2013429 (1998).","journal-title":"J. Pharm. Sci."},{"key":"9143_CR15","unstructured":"J. L. Bononi. Beta-cyclodextrin miconazole complex and beta-cyclodextrin econazole complex and their use as medical fungicides. Eur. Pat. Appli.\n                  19 (1988)."},{"key":"9143_CR16","first-page":"19","volume":"40","author":"M. Pedersen","year":"1994","unstructured":"M. Pedersen. Isolation and antimycotic effect of a genuine miconazole beta-cyclodextrin complex. Eur. J. Pharm. Biopharm.\n                  40:19\u201323 (1994).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"9143_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0378-5173(93)90197-N","volume":"90","author":"M. Pedersen","year":"1993","unstructured":"M. Pedersen, M. Edelsten, V. F. Nielsen, A. Scarpellini, S. Skytte, and C. Slot. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm.\n                  90:247\u2013254 (1993).","journal-title":"Int. J. Pharm."},{"key":"9143_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00137696-200402040-00006","volume":"2","author":"T. Loftsson","year":"2004","unstructured":"T. Loftsson, M. Brewster, and M. Masson. Role of cyclodextrins in improving oral drug delivery. Am. J. Drug Deliv.\n                  2:1\u201314 (2004).","journal-title":"Am. J. Drug Deliv."},{"key":"9143_CR19","volume-title":"Phase-solubility techniques","author":"T. Higuchi","year":"1965","unstructured":"T. Higuchi, and A. Connors. Phase-solubility techniques, Wiley-Interscience, New York, 1965."},{"key":"9143_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/0731-7085(89)80162-1","volume":"7","author":"V. Cavrini","year":"1989","unstructured":"V. Cavrini, M. D. Pietra, and R. Gatti. Analysis of miconazole and econazole in pharmaceutical formulations by derivative UV spectroscopy and liquid chromatography (HPLC). J. Pharm. Bio. Anal.\n                  7:1535\u20131543 (1989).","journal-title":"J. Pharm. Bio. Anal."},{"key":"9143_CR21","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1248\/cpb.51.914","volume":"51","author":"L. Ribeiro","year":"2003","unstructured":"L. Ribeiro, T. Loftsson, D. Ferreira, and F. Veiga. Investigation and physicochemical characterization of vinpocetine\u2013sulfobutyl ether beta-cyclodextrin binary and ternary complexes. Chem. Pharm. Bull.\n                  51:914\u2013922 (2003).","journal-title":"Chem. Pharm. Bull."},{"key":"9143_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1021\/js970233x","volume":"87","author":"M. D. Veiga","year":"1998","unstructured":"M. D. Veiga, P. J. Diaz, and F. Ahsan. Interactions of griseofulvin with cyclodextrins in solid binary systems. J. Pharm. Sci.\n                  87:891\u2013900 (1998).","journal-title":"J. Pharm. Sci."},{"key":"9143_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF01962683","volume":"10","author":"H. Doorne Van","year":"1988","unstructured":"H. Van Doorne, E. H. Bosch, and C. F. Lerk. Formation and antimicrobial activity of complexes of beta-cyclodextrin and some antimycotic imidazole derivatives. Pharm. Weekblad.\n                  10:80\u201385 (1988).","journal-title":"Pharm. Weekblad."},{"key":"9143_CR24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0939-6411(99)00043-0","volume":"48","author":"J. Jacobsen","year":"1999","unstructured":"J. Jacobsen, S. Bjerregaard, and M. Pedersen. Cyclodextrin inclusion complexes of antimycotics intended to act in the oral cavity\u2014drug supersaturation, toxicity on TR146 cells and release from a delivery system. Eur. J. Pharm. Biopharm.\n                  48:217\u2013224 (1999).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"9143_CR25","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1208\/ps060107","volume":"6","author":"M. N. Reddy","year":"2004","unstructured":"M. N. Reddy, T. Rehana, S. Ramakrishna, K. P. R. Chowdary, and P. V. Diwan. Beta-cyclodextrin complexes of celecoxib: Molecular-modeling, characterization, and dissolution studies. Aaps Pharmsci.\n                  6:E7 (2004).","journal-title":"Aaps Pharmsci."},{"key":"9143_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jpba.2004.01.012","volume":"35","author":"R. K. Verma","year":"2004","unstructured":"R. K. Verma, and S. Garg. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. J. Pharmaceut. Biomed.\n                  35:449\u2013458 (2004).","journal-title":"J. Pharmaceut. Biomed."},{"key":"9143_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ejpb.2007.03.005","volume":"67","author":"A. Figueiras","year":"2007","unstructured":"A. Figueiras, R. A. Carvalho, L. Ribeiro, J. J. Torres-Labandeira, and F. J. B. Veiga. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Eur. J. Pharm. Biopharm.\n                  67:531\u2013539 (2007).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"9143_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ijpharm.2007.08.048","volume":"350","author":"V. Barillaro","year":"2008","unstructured":"V. Barillaro, G. Dive, E. Ziemons, P. Bertholet, B. Evrard, L. Delattre, and G. Piel. Theoretical and experimental vibrational study of miconazole and its dimers with organic acids: Application to the IR characterization of its inclusion complexes with cyclodextrins. Int. J. Pharm.\n                  350:155\u2013165 (2008).","journal-title":"Int. J. Pharm."},{"key":"9143_CR29","volume-title":"Cyclodextrins and their industrial uses","author":"D. Duch\u00eane","year":"1987","unstructured":"D. Duch\u00eane. Cyclodextrins and their industrial uses, Editions de Sant\u00e9, Paris, 1987."},{"key":"9143_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0939-6411(02)00075-9","volume":"54","author":"P. Mura","year":"2002","unstructured":"P. Mura, N. Zerrouk, M. T. Faucci, F. Maestrelli, and C. Chemtob. Comparative study of ibuproxam complexation with amorphous beta-cyclodextrin derivatives in solution and in the solid state. Eur. J. Pharma. Biopharm.\n                  54:181\u2013191 (2002).","journal-title":"Eur. J. Pharma. Biopharm."},{"key":"9143_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2004.01.003","volume":"35","author":"N. B. Naidu","year":"2004","unstructured":"N. B. Naidu, K. P. R. Chowdary, K. V. R. Murthy, V. Satyanarayana, A. R. Hayman, and G. Becket. Physicochemical characterization and dissolution properties of meloxicam\u2013cyclodextrin binary systems. J. Pharmaceut. Biomed.\n                  35:75\u201386 (2004).","journal-title":"J. Pharmaceut. Biomed."},{"key":"9143_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0378-5173(02)00078-9","volume":"239","author":"M. Charoenchaitrakool","year":"2002","unstructured":"M. Charoenchaitrakool, F. Dehghani, and N. R. Foster. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-beta-cyclodextrin. Int. J. Pharm.\n                  239:103\u2013112 (2002).","journal-title":"Int. J. Pharm."},{"key":"9143_CR33","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1208\/pt0803060","volume":"8","author":"M. S. S. Cunha-Filho","year":"2007","unstructured":"M. S. S. Cunha-Filho, B. Dacunha-Marinho, J. J. Torres-Labandeira, R. Martinez-Pacheco, and M. Landin. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems. Aaps PharmSciTech.\n                  8:E68\u2013E77 (2007).","journal-title":"Aaps PharmSciTech."}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-008-9143-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9143-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-008-9143-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:48:12Z","timestamp":1559620092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-008-9143-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,31]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["9143"],"URL":"https:\/\/doi.org\/10.1208\/s12249-008-9143-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,31]]}}}